Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART

NCT02442869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2021-03-01

Study results available
· View outcomes & findings →

Summary

This pilot study tested the feasibility of utilizing an adaptive intervention strategy for college students who are suicidal when first seeking treatment at a campus clinic. Right now, the typical strategy may rely on a "one size fits all" approach, but in fact suicidal students vary greatly on what and how much they need. This study will pave the way for subsequent larger trials for clinical decision making (trying one approach, and if that doesn't work, another) to be empirically developed and tested in a subsequent large-scale multisite trial with the goal of maximizing resources in overburdened college counseling centers. This pilot study followed by a subsequent large-scale trial could eventually significantly impact service delivery to suicidal college students at college counseling centers.

Conditions

  • Suicide

Interventions

BEHAVIORAL

Stage 1 Treatment as usual (TAU)

4-8 weeks of the treatment typically provided by that counselor with the caveat that neither DBT nor CAMS can be provided.

BEHAVIORAL

Stage 1 CAMS

4-8 weeks of Collaborative Assessment and Management of Suicidality (CAMS)

BEHAVIORAL

Stage 2 CAMS

4-16 weeks of Collaborative Assessment and Management of Suicidality (CAMS)

BEHAVIORAL

Stage 2 Dialectical Behavioral Therapy (DBT)

4-16 weeks of Dialectical Behavioral Therapy (DBT)

Sponsors & Collaborators

  • The Catholic University of America

    collaborator OTHER
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • University of Nevada, Reno

    lead OTHER

Principal Investigators

  • Jacqueline Pistorello, PhD · University of Nevada, Reno

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-16
Primary Completion
2016-12-30
Completion
2016-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442869 on ClinicalTrials.gov